Schultz NA - Search Results

1

Plasma YKL-40: a potential new cancer biomarker?

Johansen JS, Schultz NA, Jensen BV. Johansen JS, et al. Among authors: schultz na. Future Oncol. 2009 Sep;5(7):1065-82. doi: 10.2217/fon.09.66. Future Oncol. 2009. PMID: 19792974 Review.

2

Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer.

Schultz NA, Christensen IJ, Werner J, Giese N, Jensen BV, Larsen O, Bjerregaard JK, Pfeiffer P, Calatayud D, Nielsen SE, Yilmaz MK, Holländer NH, Wøjdemann M, Bojesen SE, Nielsen KR, Johansen JS. Schultz NA, et al. PLoS One. 2013 Jun 26;8(6):e67059. doi: 10.1371/journal.pone.0067059. Print 2013. PLoS One. 2013. PMID: 23840582 Free PMC article.

3

YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?

Schultz NA, Johansen JS. Schultz NA, et al. Cancers (Basel). 2010 Jul 12;2(3):1453-91. doi: 10.3390/cancers2031453. Cancers (Basel). 2010. PMID: 24281168 Free PMC article.

4

MicroRNA Expression in Formalin-fixed Paraffin-embedded Cancer Tissue: Identifying Reference MicroRNAs and Variability.

Boisen MK, Dehlendorff C, Linnemann D, Schultz NA, Jensen BV, Høgdall EV, Johansen JS. Boisen MK, et al. Among authors: schultz na. BMC Cancer. 2015 Dec 29;15:1024. doi: 10.1186/s12885-015-2030-2. BMC Cancer. 2015. PMID: 26714641 Free PMC article.

5

The potential diagnostic value of serum microRNA signature in patients with pancreatic cancer.

Johansen JS, Calatayud D, Albieri V, Schultz NA, Dehlendorff C, Werner J, Jensen BV, Pfeiffer P, Bojesen SE, Giese N, Nielsen KR, Nielsen SE, Yilmaz M, Holländer NH, Andersen KK. Johansen JS, et al. Among authors: schultz na. Int J Cancer. 2016 Nov 15;139(10):2312-24. doi: 10.1002/ijc.30291. Epub 2016 Aug 16. Int J Cancer. 2016. PMID: 27464352 Free article.

6

Prognostic microRNAs in cancer tissue from patients operated for pancreatic cancer--five microRNAs in a prognostic index.

Schultz NA, Andersen KK, Roslind A, Willenbrock H, Wøjdemann M, Johansen JS. Schultz NA, et al. World J Surg. 2012 Nov;36(11):2699-707. doi: 10.1007/s00268-012-1705-y. World J Surg. 2012. PMID: 22851141

7

MicroRNA biomarkers in whole blood for detection of pancreatic cancer.

Schultz NA, Dehlendorff C, Jensen BV, Bjerregaard JK, Nielsen KR, Bojesen SE, Calatayud D, Nielsen SE, Yilmaz M, Holländer NH, Andersen KK, Johansen JS. Schultz NA, et al. JAMA. 2014 Jan 22-29;311(4):392-404. doi: 10.1001/jama.2013.284664. JAMA. 2014. PMID: 24449318

8

Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers.

Calatayud D, Dehlendorff C, Boisen MK, Hasselby JP, Schultz NA, Werner J, Immervoll H, Molven A, Hansen CP, Johansen JS. Calatayud D, et al. Among authors: schultz na. Biomark Res. 2017 Feb 21;5:8. doi: 10.1186/s40364-017-0087-6. eCollection 2017. Biomark Res. 2017. PMID: 28239461 Free PMC article.

9

Frequencies and prognostic role of KRAS and BRAF mutations in patients with localized pancreatic and ampullary adenocarcinomas.

Schultz NA, Roslind A, Christensen IJ, Horn T, Høgdall E, Pedersen LN, Kruhøffer M, Burcharth F, Wøjdemann M, Johansen JS. Schultz NA, et al. Pancreas. 2012 Jul;41(5):759-66. doi: 10.1097/MPA.0b013e31823cd9df. Pancreas. 2012. PMID: 22699145

10

MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma.

Schultz NA, Werner J, Willenbrock H, Roslind A, Giese N, Horn T, Wøjdemann M, Johansen JS. Schultz NA, et al. Mod Pathol. 2012 Dec;25(12):1609-22. doi: 10.1038/modpathol.2012.122. Epub 2012 Aug 10. Mod Pathol. 2012. PMID: 22878649 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page